High c-MET expression is frequent but not associated with early PSA recurrence in prostate cancer

by JACOBSEN, FRANK, ASHTIANI, SHARAD NOURAIE, TENNSTEDT, PIERRE, HEINZER, HANS, SIMON, RONALD, SAUTER, GUIDO, SIRMA, HÜSEYIN, TSOURLAKIS, MARIA CHRISTINA, MINNER, SARAH, SCHLOMM, THORSTEN, MICHL, UWE
Published 2013

Loss of CDKN1B/p27Kip1 expression is associated with ERG fusion-negative prostate cancer, but is unrelated to patient prognosis

by SIRMA, HÜSEYIN, BROEMEL, MARGARETHE, STUMM, LAURA, TSOURLAKIS, TINA, STEURER, STEFAN, TENNSTEDT, PIERRE, SALOMON, GEORG, MICHL, UWE, HAESE, ALEXANDER, SIMON, RONALD, SAUTER, GUIDO, SCHLOMM, THORSTEN, MINNER, SARAH
Published 2013

Heterogeneity and chronology of 6q15 deletion and ERG-fusion in prostate cancer

by Kluth, Martina, Meyer, David, Krohn, Antje, Freudenthaler, Fabian, Bauer, Melanie, Salomon, Georg, Heinzer, Hans, Michl, Uwe, Steurer, Stefan, Simon, Ronald, Sauter, Guido, Schlomm, Thorsten, Minner, Sarah
Published 2015

Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer

by Kluth, Martina, Ahrary, Ramin, Hube-Magg, Claudia, Ahmed, Malik, Volta, Heinke, Schwemin, Catina, Steurer, Stefan, Wittmer, Corinna, Wilczak, Waldemar, Burandt, Eike, Krech, Till, Adam, Meike, Michl, Uwe, Heinzer, Hans, Salomon, Georg, Graefen, Markus, Koop, Christina, Minner, Sarah, Simon, Ronald, Sauter, Guido, Schlomm, Thorsten
Published 2015